Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OceanTuniCell is a Norwegian biotechnology company specializing in the production of high-purity, medical-grade cellulose nanofibrils (CNF) derived from the marine tunicate Ciona intestinalis. The company's proprietary TUNICELL platform provides biocompatible scaffolds designed for 3D cell culture, tissue engineering, and regenerative medicine applications. These scaffolds offer superior purity and structural properties compared to plant-based or synthetic alternatives, making them ideal for clinical-grade bioprinting and cell-based therapies. OceanTuniCell serves the global research and clinical markets, focusing on advancing the development of complex tissue models and implantable medical devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OceanTuniCell.